Abstract
Objective
Lung cancer has emerged as a leading cause of cancer death in the world. Current therapies are ineffective, thus new approaches are needed to improve the therapeutic ratio. RNA interference (RNAi) has shown promise in gene silencing in vitro, the potential of which in developing new methods for the therapy of non-small-cell lung cancer (NSCLC) needs to be further tested in vivo. In this study, chemically synthesized double-stranded RNA (dsRNA) targeting epidermal growth factor receptor (EGFR) was transfected into NSCLC cell line SPC-A1 cells and established the tumor burdened athymic nude mice model to investigate whether dsRNA could induce gene silencing in NSCLC cells in vivo.
Methods
SPC-A1 was transfected with EGFR sequence-specific dsRNA formulated with Lipofectamine 2000. SPC-A1 cells (1 × 107/mL) in 200 μL were injected s.c. into the left flank area of the mice to establish the tumor burdened athymic nude mice model. Calculate the tumor growth inhibition rate by measuring the diameter and the weight of the tumor. Immunohistochemistry and Western blot were used to monitor the reduction in the production of the EGFR protein. Realtime RT-PCR was used to detect the silencing of the EGFR mRNA level.
Results
It displayed that EGFR sequence specific dsRNA (dsRNA-EGFR) significantly inhibited the tumor growth in vivo. The tumor growth inhibition rate was 75.03%. The dsRNA-EGFR sequence specifically silenced EGFR with 53.6% of down-regulation of EGFR protein production and 32.3% of silencing of EGFR mRNA level.
Conclusion
DsRNA-EGFR showed a blockbuster effect in downregulation of EGFR mRNA level and protein production, and inhibition of tumor growth in vivo.
Similar content being viewed by others
References
Hida T, Ogawa S, Park JC, et al. Gefitinib for the treatment of nonsmall-cell lung cancer. Expert Rev Anticancer Ther, 2009, 9: 17–35.
Fong T, Morgensztern D, Govindan R. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer. J Thorac Oncol, 2008, 3: 303–310.
von Eije KJ, ter Brake O, Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol, 2008, 82: 2895–2903.
Ploner C, Rainer J, Niederegger H, et al. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia, 2008, 22: 370–377.
Zhang M, Zhang X, Bai CX, et al. Effect of RNA interference on epidermal growth factor receptor expression in A549 Cells. Chin J Oncol (Chinese), 2004, 26: 713–717.
Zhang M, Zhang X, Bai CX, et al. Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer cells. Genet Vaccines Ther, 2005, 30: 1–12.
Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med, 2008, 358: 1160–1174.
Kalluri R, Kanasaki K. RNA interference: generic block on angiogenesis. Nature, 2008, 452: 543–545.
Kloc A, Zaratiegui M, Nora E, et al. RNA interference guides histone modification during the S Phase of chromosomal replication. Curr Biol, 2008, 18: 490–495.
Nguyen T, Menocal EM, Harborth J, et al. RNAi therapeutics: An update on delivery. Curr Opin Mol Ther, 2008, 10: 158–167.
Xu Z, Li X, Liu R, et al. Inhibition of expression of rna polymerase with small interfering RNAs targeting a conserved motif in the respective viral genes in viruses of the family Flaviviridae. Acta Virol, 2007, 51: 195–201.
Garriga D, Navarro A, Querol-Audí J, et al. Activation mechanism of a noncanonical RNA-dependent RNA polymerase. Proc Natl Acad Sci USA, 2007, 104: 20540–20545.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant from the Natural Science Foundation of Shanghai (No. 03ZR14004).
Rights and permissions
About this article
Cite this article
Zhang, M., Bai, C., Zhang, X. et al. Antitumor effect of RNA interference on non-small-cell lung cancer in vivo. Chin. -Ger. J. Clin. Oncol. 8, 463–466 (2009). https://doi.org/10.1007/s10330-009-0098-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-009-0098-3